Compare CLLS & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | FOA |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 272.8M |
| IPO Year | 2007 | N/A |
| Metric | CLLS | FOA |
|---|---|---|
| Price | $4.98 | $23.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $8.00 | ★ $29.75 |
| AVG Volume (30 Days) | ★ 124.5K | 100.5K |
| Earning Date | 11-07-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $82,551,000.00 | ★ $318,296,000.00 |
| Revenue This Year | N/A | $21.21 |
| Revenue Next Year | $58.00 | $10.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.04 | N/A |
| 52 Week Low | $1.10 | $16.58 |
| 52 Week High | $5.48 | $32.40 |
| Indicator | CLLS | FOA |
|---|---|---|
| Relative Strength Index (RSI) | 69.02 | 59.13 |
| Support Level | $4.90 | $22.96 |
| Resistance Level | $5.35 | $24.35 |
| Average True Range (ATR) | 0.28 | 0.78 |
| MACD | 0.14 | 0.15 |
| Stochastic Oscillator | 85.56 | 79.96 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.